Madder () Alleviates Myocardial Ischemia-Reperfusion Injury by Protecting Endothelial Cells from Apoptosis and Inflammation

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2023 Mar 6

PMID 36875688

Authors

Jinwei Gao

Zheng Wang

Zhangzhang Ye

Affiliations

Soon will be listed here.

Abstract

Objective: Ischemia-reperfusion injury often occurs in organ transplantation, coronary heart disease, ischemic heart disease, and other diseases, which greatly reduces clinical efficacy. This study examined the effectiveness of madder as a medicine to treat ischemia-reperfusion injury.

Methods: The efficacy of madder was evaluated by measuring myocardial infarction size, coronary outflow volume, myocardial contraction rate, activation of inflammatory factors, autophagy factors, apoptosis factors, and related pathway genes in mice.

Results: The results indicated that treatment with madder can effectively reduce the area of myocardial infarction and restore arterial blood flow velocity and myocardial contractility in mice. Additionally, madder treatment inhibited the expression of inflammatory factors, autophagy factors, and apoptosis factors in mice and reduced the degree of myocardial cell injury. Studies have also shown that madder treatment can alleviate myocardial ischemia-reperfusion injury in mice and inhibit the occurrence of inflammatory response by inhibiting the activity of the NF-B pathway.

Conclusion: The results showed that madder was effective against ischemia-reperfusion injury, thus showing potential as a clinical drug for treating ischemia-reperfusion injury.

Citing Articles

L. Attenuates Diabetic Neuropathy by Inhibiting Apoptosis and Oxidative Stress in Rats.

Bana S, Kumar N, Sartaj A, Alhalmi A, Qurtam A, Nasr F Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004451 PMC: 10674165. DOI: 10.3390/ph16111586.

A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023.

Wang Y, Guo L, Zhang Z, Fu S, Huang P, Wang A Front Cardiovasc Med. 2023; 10:1180792.

PMID: 37383699 PMC: 10293770. DOI: 10.3389/fcvm.2023.1180792.

References

Ling Q, Yu X, Wang T, Wang S, Ye Z, Liu J . Roles of the Exogenous H2S-Mediated SR-A Signaling Pathway in Renal Ischemia/ Reperfusion Injury in Regulating Endoplasmic Reticulum Stress-Induced Autophagy in a Rat Model. Cell Physiol Biochem. 2017; 41(6):2461-2474. DOI: 10.1159/000475915. View

Sanada S, Komuro I, Kitakaze M . Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 2011; 301(5):H1723-41. DOI: 10.1152/ajpheart.00553.2011. View

Liu X, Yang Z, Liu X . Fas/FasL induces myocardial cell apoptosis in myocardial ischemia-reperfusion rat model. Eur Rev Med Pharmacol Sci. 2017; 21(12):2913-2918. View

Yan L, Vatner D, Kim S, Ge H, Masurekar M, Massover W . Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A. 2005; 102(39):13807-12. PMC: 1224362. DOI: 10.1073/pnas.0506843102. View

Frank A, Bonney M, Bonney S, Weitzel L, Koeppen M, Eckle T . Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth. 2012; 16(3):123-32. PMC: 3457795. DOI: 10.1177/1089253211436350. View

Frohlich G, Meier P, White S, Yellon D, Hausenloy D . Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013; 34(23):1714-22. DOI: 10.1093/eurheartj/eht090. View

Yellon D, Hausenloy D . Myocardial reperfusion injury. N Engl J Med. 2007; 357(11):1121-35. DOI: 10.1056/NEJMra071667. View

Rentoukas E, Tsarouhas K, Tsitsimpikou C, Lazaros G, Deftereos S, Vavetsi S . The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2009; 145(2):257-258. DOI: 10.1016/j.ijcard.2009.08.037. View

Narayanan S, Dave K, Perez-Pinzon M . Ischemic preconditioning and clinical scenarios. Curr Opin Neurol. 2012; 26(1):1-7. PMC: 3752400. DOI: 10.1097/WCO.0b013e32835bf200. View

10.

Lopez-Neblina F, Toledo A, Toledo-Pereyra L . Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg. 2005; 18(6):335-50. DOI: 10.1080/08941930500328862. View

11.

Zeng M, Wei X, Wu Z, Li W, Li B, Fei Y . Reactive oxygen species contribute to simulated ischemia/reperfusion-induced autophagic cell death in human umbilical vein endothelial cells. Med Sci Monit. 2014; 20:1017-23. PMC: 4074109. DOI: 10.12659/MSM.890897. View

12.

Jiang F . Autophagy in vascular endothelial cells. Clin Exp Pharmacol Physiol. 2016; 43(11):1021-1028. DOI: 10.1111/1440-1681.12649. View

13.

Chakrabortee S, Liu Y, Zhang L, Matthews H, Zhang H, Pan N . Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity. Biochem J. 2011; 442(3):507-15. DOI: 10.1042/BJ20111661. View

14.

Lodi S, Sharma V, Kansal L . The protective effect of Rubia cordifolia against lead nitrate-induced immune response impairment and kidney oxidative damage. Indian J Pharmacol. 2011; 43(4):441-4. PMC: 3153710. DOI: 10.4103/0253-7613.83118. View

15.

De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R . A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature. 2011; 476(7360):336-40. PMC: 4141877. DOI: 10.1038/nature10230. View

16.

Zhu J, Yao K, Wang Q, Guo J, Shi H, Ma L . Ischemic Postconditioning-Regulated miR-499 Protects the Rat Heart Against Ischemia/Reperfusion Injury by Inhibiting Apoptosis through PDCD4. Cell Physiol Biochem. 2016; 39(6):2364-2380. DOI: 10.1159/000452506. View

17.

Jaffe R, Dick A, Strauss B . Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc Interv. 2010; 3(7):695-704. DOI: 10.1016/j.jcin.2010.05.004. View

18.

Smith R, Hartley R, Murphy M . Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal. 2011; 15(12):3021-38. DOI: 10.1089/ars.2011.3969. View

19.

Heusch G, Boengler K, Schulz R . Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol. 2010; 105(2):151-4. DOI: 10.1007/s00395-009-0080-9. View

20.

Yuan X, Jing S, Wu L, Chen L, Fang J . Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway. Exp Ther Med. 2014; 8(3):973-977. PMC: 4113531. DOI: 10.3892/etm.2014.1820. View